L R Stillerman1, S B Gunn, J C Hart, W A Engle. 1. Department of Respiratory Care, James Whitcomb Riley Hospital for Children, Indiana University School of Medicine, Indianapolis 46202-5210, USA.
Abstract
OBJECTIVE: The purpose of this study was to evaluate the impact of exogenous surfactant on the duration of extracorporeal membrane oxygenation needed to support neonates. STUDY DESIGN: Retrospective case review. RESULTS: The duration of extracorporeal membrane oxygenation decreased from 112 +/- 43.3 hours to 76 +/- 17.9 hours. There was no difference in duration of mechanical ventilation, duration of supplemental oxygen, incidence of chronic lung disease, or length of hospital stay. CONCLUSION: Surfactant administered soon after initiation of extracorporeal membrane oxygenation results in a significant reduction in the duration of extracorporeal support for neonates.
OBJECTIVE: The purpose of this study was to evaluate the impact of exogenous surfactant on the duration of extracorporeal membrane oxygenation needed to support neonates. STUDY DESIGN: Retrospective case review. RESULTS: The duration of extracorporeal membrane oxygenation decreased from 112 +/- 43.3 hours to 76 +/- 17.9 hours. There was no difference in duration of mechanical ventilation, duration of supplemental oxygen, incidence of chronic lung disease, or length of hospital stay. CONCLUSION: Surfactant administered soon after initiation of extracorporeal membrane oxygenation results in a significant reduction in the duration of extracorporeal support for neonates.
Authors: Michael Hermon; Gudrun Burda; Christoph Male; Harald Boigner; Walter Ponhold; August Khoss; Wolfgang Strohmaier; Gerhard Trittenwein Journal: Crit Care Date: 2005-10-25 Impact factor: 9.097